EBV and further emerging directions towards increased precision in gastric cancer treatment
- PMID: 36237269
- PMCID: PMC9552089
- DOI: 10.21037/tcr-22-2024
EBV and further emerging directions towards increased precision in gastric cancer treatment
Conflict of interest statement
Conflicts of Interest: The authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-22-2024/coif). EDN reports that he is the coordinator of research grants received from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, 2014/26897-0) and the Brazilian Ministry of Health (PRONON SIPAR 2500.055-167/2015-23) to support scientific research at the Laboratory of Medical Genomics, A.C.Camargo Cancer Center. These agencies had no role in the reporting of results or published manuscripts. The other authors have no conflicts of interest to declare.
Comment on
-
A potential EBV-related classifier is associated with the efficacy of immunotherapy in gastric cancer.Transl Cancer Res. 2022 Jul;11(7):2084-2096. doi: 10.21037/tcr-22-461. Transl Cancer Res. 2022. PMID: 35966300 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources